Bio pharma supply chain risk and pharmaceutical supply chain strategy Frequent disruptions and shifting U.S. tariffs are transforming bio pharma supply chain risk, prompting the adoption of forward-looking pharmaceutical supply chain strategy. Organizations are focusing on diversification, localization, and analytics-driven risk management to offset cost pressures, maintain supply continuity, and support patient needs amid policy and market volatility.For more ifno: https://www.zs.com/insights/us-pharma-policy-strategies-to-future-proof-your-supply-chain